Description: Efavirenz 600 mg and Emtricitabine 200 mg and Tenofovir Disoproxil Fumarate Tablets 300 mg Drugs supplier, response of Efavirenz 600 mg and Emtricitabine 200 mg and Tenofovir Disoproxil Fumarate Tablets 300 mg, treatment of Efavirenz 600 mg and Emtricitabine 200 mg and Tenofovir Disoproxil Fumarate Tablets 300 mg, Efavirenz 600 mg and Emtricitabine 200 mg and Tenofovir Disoproxil Fumarate Tablets 300 mg Drugs Medicines, Efavirenz 600 mg and Emtricitabine 200 mg and Tenofovir Disoproxil Fumarate Tablets 300 mg manufacturers. Product Name: Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablets Brand Name: Generics Strength: 600mg/200mg/300mg Dosage Form: Film-coated tablets Packing: 120 Tab Bottle Route of Administration: For Oral Use Only Pack Insert/Leaflet: PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) Regulatory Documents: COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier Therapeutic use: Antivirals Indication: The indication applied is for the use of Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva in the treatment of Human immunodeficiency virus-1 (HIV-1) infection in adults aged 18 years and over with virologic suppression to HIV-1 RNA levels of < 50 copies/ml on their current combination antiretroviral therapy. Storage: Store protected from moisture at a temperature not exceeding 30°C.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 233 KB
